共 50 条
- [49] Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials DIABETES OBESITY & METABOLISM, 2021, 23 (12): : 2763 - 2774